Emergex
  • About Us
      • Team
      • Board of Directors
      • Special Advisors
      • Partners
  • Technology
      • Advantages of Emergex’s Vaccines
  • Pipeline
  • Media Centre
    • In the News
    • Press Releases
  • Careers
  • Contact Us
  • Menu Menu
You are here: Home1 / About Us2 / Partners

Drawing on a rich scientific heritage and extensive international research, Emergex has developed collaborations in the US, EU, Singapore and Brazil with leading vaccine research bodies, including George Mason University in the US, the Institute of Molecular and Cell Biology (IMCB) of Singapore, and Brazil-based Bio-Manguinhos/Fiocruz.

Emergex will consider further collaboration and partnerships to accelerate its pipeline of vaccine candidates.

Please contact info@emergexvaccines.com to discuss opportunities with Emergex Vaccines and to arrange a meeting.

© EMERGEX VACCINES

Website maintained by Digital Trading

  • Contact Us
LinkedIn
Scroll to top